ABUS:NASDAQ
Arbutus Biopharma Corp
$4.11
arrow_downward
-0.96%(-0.040) 1D
$4.12
arrow_upward
+0.27% (+0.011)bedtimeAfter hours
Closed: Oct 13, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ABUS...
Open
$4.13
High
$4.16
Low
$4.05
Mkt. cap
814.21M
Avg. vol.
6.78M
Volume
0.00
P/E ratio
5.25
52-wk high
$5.45
52-wk low
$3.50
EPS
$0.78
Beta
0.76
Shares outstanding
198.11M
No. of employees
19
Open
$4.13
High
$4.16
Low
$4.05
Mkt. cap
814.21M
Avg. vol.
6.78M
Volume
0.00
P/E ratio
5.25
52-wk high
$5.45
52-wk low
$3.50
EPS
$0.78
Beta
0.76
Shares outstanding
198.11M
No. of employees
19
News stories
From web sources and news partners
Investing.com Nigeria
·
3 days ago
Form 4 Arbutus Biopharma Corp For: 10 October By Investing.com
Profile
Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection.
It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007. Wikipedia
About Arbutus Biopharma Corp
CEOWilliam H. Collier
Employees19
Founded2007
HeadquartersWarminster Township, Pennsylvania, United States
SectorBiotechnology
Websitearbutusbio.com